Therapy Areas: Vaccines
Cadila signs manufacturing and technology transfer agreement with Enzychem for its COVID-19 vaccine
24 November 2021 -

Indian pharmaceutical company Cadila Healthcare (NSE:CADILAHC) has entered into a manufacturing and technology transfer agreement with South Korea's Enzychem Lifesciences (Kosdaq:183490.KQ), a developer of novel small molecule therapeutics, Reuters news agency reported on Wednesday.

This agreement is for Cadila's DNA COVID-19 vaccine, ZyCoV-D.

Login
Username:

Password: